Immunotherapy as a treatment for Stroke: Utilizing regulatory T cells
Brain Hemorrhages · 2023-09 · 4 (3) · 147-153
DOI: 10.1016/j.hest.2023.02.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Hemorrhages, 2023-09. Verfasst von Yuanwei Li und 5 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Hunan Province of China.
Themen: Schlaganfall
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Hunan Province of China
Zitieren
APA
Li, Y., McBride, D. W., Tang, Y., Doycheva, D., Zhang, J. H., & Tang, Z. (2023). Immunotherapy as a treatment for Stroke: Utilizing regulatory T cells. Brain Hemorrhages, 4(3), 147-153. https://doi.org/10.1016/j.hest.2023.02.003
Vancouver
Li Y, McBride DW, Tang Y, Doycheva D, Zhang JH, Tang Z. Immunotherapy as a treatment for Stroke: Utilizing regulatory T cells. Brain Hemorrhages. 2023;4(3):147-153. doi:10.1016/j.hest.2023.02.003
BibTeX
@article{Li2023,
author = {Li, Yuanwei and McBride, Devin W. and Tang, Yingxin and Doycheva, Desislava and Zhang, John H. and Tang, Zhouping},
title = {Immunotherapy as a treatment for Stroke: Utilizing regulatory T cells},
journal = {Brain Hemorrhages},
year = {2023},
volume = {4},
number = {3},
pages = {147--153},
doi = {10.1016/j.hest.2023.02.003}
}
EUVIMED